Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05132283 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trial| NCT Number | NCT05132283 |
| Lead Sponsor | Brigham and Women's Hospital |
| Conditions | Urologic Cancer, Lymph Node Metastasis |
| Enrollment | 20 participants |
| Start Date | 2022-04-01 |
| Primary Completion | 2027-12-01 (estimated) |
| Study Completion | 2028-12-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-09-30 |